https://www.ajmc.com/view/segment-9---the-use-of-expensive-or-new-immunotherapies-in-clinical-pathways
In regard to updating pathways and guidelines, Dr Sonnad asked about the opportunity for newer, expensive immunotherapies to be included in a pre-determined...
segmentuseexpensivenewimmunotherapies
https://www.pairxbio.com/
PairX Bio is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The PairX...
next generationbiocancerimmunotherapies
https://bachrachfamilyfoundation.org/our-grants/spherical-nucleic-acids-snas-as-structural-immunotherapies-for-blood-cancers/
Spherical Nucleic Acids (SNAs) as Structural Immunotherapies for Blood Cancers The Mirkin group at Northwestern University is spurring a paradigm shift in the...
spherical nucleic acidsfor bloodsnasstructuralimmunotherapies
https://pubmed.ncbi.nlm.nih.gov/38593797/
Many patient-derived tumor models have emerged recently. However, their potential to guide personalized drug selection remains unclear. Here, we report...
patientderivedtumorlikecell
https://www.uoflnews.com/section/science-and-tech/uofl-and-uofl-health-receive-11-5-million-from-nih-to-develop-new-immunotherapies-for-cancer-patients/
uoflhealthreceivemilliondevelop
https://nxitherapeutics.com/
NXI Therapeutics - Creating Tomorrow's Immunotherapies | The beginning of a new era of specificity and safety in the immunosuppressive therapy market
therapeuticscreatingtomorrowimmunotherapies
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.737615/full
In the last 20 years, remarkable advances in the field of immunotherapy have led to new therapeutic options for patients with a wide range of cancer types. A...
t cellsfrontierseditorialcancerimmunotherapies